Silence Therapeutics plc (SLNCF)

Silence Therapeutics Revenue

In the year 2025, Silence Therapeutics had annual revenue of $559.00K, down -98.71%. Silence Therapeutics had revenue of $34.00K in the quarter ending December 31, 2025, a decrease of -99.87%.

• Revenue: 559.00K
• Revenue Growth: -98.71%
• P/S Ratio: 529.80
• Revenue / Employee: 4.82K
• Employees: 116
• Market Cap: 296.16M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	559.00K	-42.70M	-98.71%
Dec 31, 2024	43.26M	10.96M	33.92%
Dec 31, 2023	32.30M	10.65M	49.17%
Dec 31, 2022	21.66M	4.87M	29.01%
Dec 31, 2021	16.78M	9.29M	124.07%
Dec 31, 2020	7.49M	7.17M	2,215.11%
Dec 31, 2019	323.57K	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	21.62K	-928.69K	-97.72%
Dec 31, 2016	950.31K	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	23.37K	-170.40K	-87.94%
Dec 31, 2013	193.77K	-	-